article thumbnail

Who’s saying what? Blockchain mentions in company filings of pharmaceutical industry increased by 17% in Q1 2023

Pharmaceutical Technology

GlobalData’s Blockchain Market Size, Share, Trends, and Segment Forecast to 2030 report offers insights on application of blockchain in healthcare and other key sectors. For further understanding of GlobalData's Blockchain Market Size, Share, Trends, and Segment Forecast to 2030 buy the report here.

article thumbnail

Sorry, the Inflation Bill won’t lower healthcare costs

World of DTC Marketing

1ne: A new analysis predicts that by 2030, 48.9% This is going to lead to a lot of health problems and associated costs. Increased provider consolidation has decreased individual market competition, in which lower prices, improved productivity, and innovation can occur. of adults in the United States will be obese, and 24.2%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eli Lilly achieving significant gains in obesity results

Pharmaceutical Technology

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. There have been several Phase III trials for Mounjaro, with SURMOUNT-1 demonstrating a weight loss of up to 22.5%

Leads 98
article thumbnail

4D Molecular’s Fabry gene therapy program on FDA clinical hold

Pharmaceutical Technology

4DMT is creating a gene therapy using an adeno-associated viral vector (AAV) and there is currently competition from several early-stage therapies in trial, such as Sangamo Therapeutics’s Fabry gene therapy that is currently at Phase III, which also uses AAV, and as of November 2022 has reported it is progressing to late-stage plans.

FDA 105
article thumbnail

$2 billion mRNA-based oncology therapy market anticipated by 2029

European Pharmaceutical Review

BioNTech is anticipated to lead the market with a predicted $885 million in sales, and a 44.6 billion by 2030 BioNTech Development of mRNA-based oncology therapies for German biotech BioNTech is progressing. Omega Therapeutics’s share suggests increasing competition and diversification in this innovative field,” concluded Podder.

article thumbnail

Five Ways ASCs Can Use Price Transparency to Strengthen Their Market Position

Clarify Health

As both government and commercial payers direct a greater share of volume to out-patient facilities and patient demand for same-day service increases, opportunity and competition in the ambulatory surgical center (ASC) space are increasing. Is there an ASC in your market you should merge with or acquire?

article thumbnail

Sun Pharma agrees deal to buy alopecia player Concert

pharmaphorum

India’s Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss. The $11.50 The report predicts that the alopecia areata market will grow to as much as $2.5

Pharma 82